EU SaMD Regulations: Mastering App Store Compliance and 'Making Available' Rules

This episode explores the critical new regulatory focus from Europe's Medical Device Coordination Group (MDCG) on Software as a Medical Device (SaMD) distributed via online platforms. We discuss how the concept of 'making available on the market' now directly applies to app stores, forcing manufacturers to integrate platform listings, version control, and geographic restrictions into their core compliance and Quality Management Systems to avoid significant penalties. Key Questions: - What does 'making available on the market' mean for a medical app? - How can your app store listing create a serious compliance risk? - Are you responsible for ensuring only the correct version of your SaMD is downloadable? - How do you manage updates and change notices for an app distributed to thousands of users? - Can you use an app store's geographic restrictions to manage regulatory approvals? - What are the consequences of non-compliance for SaMD on digital marketplaces? - How does this new guidance impact your Quality Management System (QMS)? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access with a powerful combination of local expertise and advanced AI. For SaMD innovators, our experts develop efficient regulatory strategies and help manage technical dossiers for submission to authorities worldwide. We ensure your product remains compliant through post-market surveillance and continuous regulatory monitoring. Our AI-powered data tools can accelerate your research and document management. Let us help you navigate the complexities of global expansion. Visit us at https://pureglobal.com, contact [email protected], or explore our free AI tools and database at https://pureglobal.ai.